When wishful thinking leads to a misty-eyed appraisal: the story of the adjuvant colon cancer trials with edrecolomab
- PMID: 19273695
- DOI: 10.1200/JCO.2008.20.6284
When wishful thinking leads to a misty-eyed appraisal: the story of the adjuvant colon cancer trials with edrecolomab
Comment in
-
EpCAM as a target in cancer therapy.J Clin Oncol. 2010 May 20;28(15):e239-40; author reply e241-2. doi: 10.1200/JCO.2009.26.8540. Epub 2010 Apr 12. J Clin Oncol. 2010. PMID: 20385979 No abstract available.
Comment on
-
Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.J Clin Oncol. 2009 Apr 20;27(12):1941-7. doi: 10.1200/JCO.2008.18.5710. Epub 2009 Mar 9. J Clin Oncol. 2009. PMID: 19273708 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical